Clinical Trial

SKB118 Injection in Advanced Solid Tumors

Name: SKB118 Injection in Advanced Solid Tumors — clinical trial record (NCT07586943)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB118 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.

Trial Details

NCT Number	NCT07586943
Lead Sponsor	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	332 participants
Start Date	2026-06
Primary Completion	2029-12 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-14